Press Releases - 2023-07-13

Date	Title	Company
13-Jul-2023	Thermo Fisher Scientific Elects New Director to Board	Businesswire
13-Jul-2023	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	Businesswire
13-Jul-2023	Paysign to Host Second Quarter 2023 Earnings Call	Businesswire
13-Jul-2023	MEI Pharma Postpones Special Meeting of Shareholders	Businesswire
13-Jul-2023	Vistagen Receives Notice of Allowance for AV-101 Canadian Patent for Treatment of Dyskinesia Related to Levodopa Therapy for Parkinson’s Disease	Businesswire
13-Jul-2023	ExThera Medical Announces FDA Approval of IDE Application for Use of the OncoBindTM Extracorporeal Procedure to Remove Circulating Tumor Cells in Patients with Pancreatic Cancer	Businesswire
13-Jul-2023	Global Face Shield Market to Reach $1.4 Billion by 2030: Growing Popularity of Polycarbonate Face Shield Displays Fuels the Sector - ResearchAndMarkets.com	Businesswire
13-Jul-2023	Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial	Kuros Biosciences AG
13-Jul-2023	Rarebase Announces Promotion of Chris Moxham to President	Businesswire
13-Jul-2023	Inizio Engage launches Patient Access Services – an integrated suite of patient support services to enhance access and adherence for specialty therapies	Inizio Engage
13-Jul-2023	Wipro Announces Results for the Quarter ended June 30, 2023, Delivers Net Income growth of 12% YoY	Businesswire
13-Jul-2023	Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery	Businesswire
13-Jul-2023	Virpax Pharmaceuticals Files Provisional Patent Application for Intranasal Delivery	Businesswire
13-Jul-2023	Model N Announces Date of Third Quarter Fiscal Year 2023 Financial Results	Businesswire
13-Jul-2023	Propanc Biopharma Peer Reviewed Scientific Article Reaches 3,000 Reads	Businesswire
13-Jul-2023	Simulations Plus Releases ADMET Predictor® 11	Businesswire
13-Jul-2023	Thermo Fisher Scientific Launches Scalable Diomni Enterprise Software for Molecular Diagnostics Labs and Test Developers	Businesswire
13-Jul-2023	Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5%	Businesswire
13-Jul-2023	First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services	Businesswire
13-Jul-2023	KSQ Therapeutics Enters Worldwide License Agreement with Roche for KSQ-4279, a Clinical-Stage USP1 Inhibitor for Cancer	Businesswire